ARGATROBAN
As listed in the register: ARGATROBAN
1 mg · solution
- Prescription only
- Blood, clotting and anaemia
- Active substance
- Argatroban
- Used in
- Blood, clotting and anaemia
- Made by
- Sandoz Canada Incorporated
- Source
- Official label
Quoted from the official source. Not yet reviewed by Mediclarum — the leaflet in your pack is authoritative.
What it is for
Mediclarum has not yet retrieved and stored the official label for this product, so none of its text is shown here. Open the official leaflet
How it works
From the US prescribing label for the same active substance (Argatroban). It describes the substance, not this exact product.
Argatroban is a direct thrombin inhibitor that reversibly binds to the thrombin active site.
Argatroban does not require the co-factor antithrombin III for antithrombotic activity.
The main route of argatroban metabolism is hydroxylation and aromatization of the 3-methyltetrahydroquinoline ring in the liver.
Argatroban is excreted primarily in the feces, presumably through biliary secretion.
Quoted from the prescribing label, sections “Mechanism of Action” and “Pharmacokinetics”. DailyMed · 2026-08-20
Safety of the active substance
From the US prescribing label for the same active substance (Argatroban). It describes the substance, not this exact product.
- Argatroban is contraindicated in Patients with major bleeding [ see Warnings and Precautions ( 5.1 ) ].
- Patients with history of hypersensitivity to argatroban.
- Airway, skin, and generalized hypersensitivity reactions have been reported [ see Adverse Reactions ( 6.1 ) ].
- Major bleeding ( 4 ) History of hypersensitivity to this product ( 4 )
The most common (greater than 5%) adverse reactions were dyspnea, hypotension, fever, diarrhea, sepsis, and cardiac arrest.
Quoted from the US prescribing label for the same active substance. Your own pack’s leaflet is the authority for your product. DailyMed
Same active substance, strength and form in other countries
Matched on active substance, strength and kind of form only. This is not a statement that the products are equivalent or interchangeable: other ingredients, release and approved uses can differ — ask a pharmacist before swapping.
Medicine passport: one printable page to show a pharmacist abroad
United StatesNo exact match for this strength and form
SpainNo exact match for this strength and form
NetherlandsNo exact match for this strength and form
SwitzerlandNo exact match for this strength and form
Details
| Made by | Sandoz Canada Incorporated |
|---|---|
| Active substance | Argatroban |
| Used in | Blood, clotting and anaemia |
| Strength | 1 mg |
| Form | solution |
| Classification | B01AE03 · Blood, clotting and anaemia |
| Route | intravenous |
| Dispensing (as stated by the register) | PRESCRIPTION |
| Status | Marketed |
| Marketed | Yes, according to the register |
| DIN | 02548968 |
| DPD drug code | 103778 |
Source: Drug Product Database · 2026-09-30 · not reviewed by a clinician
Contains information licensed under the Open Government Licence – Canada. Reuse terms: Open Government Licence – Canada.
Same active substance
These contain the same substance. That does not mean one can replace another — ask a pharmacist.